NasdaqCM - Delayed Quote USD
KALA BIO, Inc. (KALA)
4.3800
-0.3600
(-7.59%)
At close: 4:00:01 PM EDT
4.3200
-0.06
(-1.37%)
After hours: 4:09:06 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -2.04 | -1.11 | -5.46 | 0 |
| Low Estimate | -2.04 | -1.11 | -5.46 | 0 |
| High Estimate | -2.04 | -1.11 | -5.46 | 0 |
| Year Ago EPS | -2.45 | -1.93 | -7.46 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -4.58 | -2.71 | -2.47 | -2.54 |
| EPS Actual | -2.45 | -1.93 | -1.23 | -1.01 |
| Difference | 2.13 | 0.78 | 1.24 | 1.53 |
| Surprise % | 46.61% | 28.78% | 50.14% | 60.11% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -2.04 | -1.11 | -5.46 | 0 |
| 7 Days Ago | -2.74 | -1.29 | -7.07 | 0 |
| 30 Days Ago | -2.74 | -1.29 | -7.07 | 0 |
| 60 Days Ago | -1.3 | -1.29 | -6.02 | 0 |
| 90 Days Ago | -1.3 | -1.29 | -6.02 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KALA | 16.58% | 42.49% | 26.83% | -- |
| S&P 500 | 13.13% | 2.46% | 7.54% | 14.07% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/23/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/4/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/15/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 8/19/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/17/2024 |
Related Tickers
CTMX CytomX Therapeutics, Inc.
2.8200
+4.44%
GBIO Generation Bio Co.
0.3910
-8.02%
CLSD Clearside Biomedical, Inc.
0.8081
-0.23%
TRVI Trevi Therapeutics, Inc.
6.25
-3.99%
ASMB Assembly Biosciences, Inc.
17.05
-1.16%
ELEV Elevation Oncology, Inc.
0.3795
-0.84%
LRMR Larimar Therapeutics, Inc.
3.1000
+6.53%
SLDB Solid Biosciences Inc.
4.6100
-4.55%
CRVS Corvus Pharmaceuticals, Inc.
4.5000
+5.88%
ADVM Adverum Biotechnologies, Inc.
2.5900
-7.17%